Bio-Rad Laboratories Inc.

AI Score

0

Unlock

367.96
9.09 (2.53%)
At close: Jan 28, 2025, 2:03 PM

Bio-Rad Laboratories Statistics

Share Statistics

Bio-Rad Laboratories has 28.03M shares outstanding. The number of shares has increased by -1.95% in one year.

Shares Outstanding 28.03M
Shares Change (YoY) n/a
Shares Change (QoQ) 0.3%
Owned by Institutions (%) n/a
Shares Floating 23.44M
Failed to Deliver (FTD) Shares 3
FTD / Avg. Volume 0%

Short Selling Information

The latest short interest is 551.64K, so 1.97% of the outstanding shares have been sold short.

Short Interest 551.64K
Short % of Shares Out 1.97%
Short % of Float 2.36%
Short Ratio (days to cover) 2.94

Valuation Ratios

The PE ratio is -14.8 and the forward PE ratio is 31.29.

PE Ratio -14.8
Forward PE 31.29
PS Ratio 3.53
Forward PS 3.6
PB Ratio 1.08
P/FCF Ratio 43.21
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Bio-Rad Laboratories Inc. has an Enterprise Value (EV) of 10.84B.

EV / Earnings -17
EV / Sales 4.06
EV / EBITDA -17.82
EV / EBIT 32.08
EV / FCF 49.65

Financial Position

The company has a current ratio of 5.83, with a Debt / Equity ratio of 0.16.

Current Ratio 5.83
Quick Ratio 4.34
Debt / Equity 0.16
Total Debt / Capitalization 13.85
Cash Flow / Debt 0.27
Interest Coverage 6.83

Financial Efficiency

Return on equity (ROE) is -0.07% and return on capital (ROIC) is 2.5%.

Return on Equity (ROE) -0.07%
Return on Assets (ROA) -0.05%
Return on Capital (ROIC) 2.5%
Revenue Per Employee 346.92K
Profits Per Employee -82.77K
Employee Count 7.70K
Asset Turnover 0.22
Inventory Turnover 1.59

Taxes

Income Tax -212.78M
Effective Tax Rate 0.25

Stock Price Statistics

The stock price has increased by 8.89% in the last 52 weeks. The beta is 0.94, so Bio-Rad Laboratories 's price volatility has been higher than the market average.

Beta 0.94
52-Week Price Change 8.89%
50-Day Moving Average 337.91
200-Day Moving Average 317.99
Relative Strength Index (RSI) 61.8
Average Volume (20 Days) 183.56K

Income Statement

In the last 12 months, Bio-Rad Laboratories had revenue of 2.67B and earned -637.32M in profits. Earnings per share was -21.82.

Revenue 2.67B
Gross Profit 1.43B
Operating Income 337.80M
Net Income -637.32M
EBITDA -608.26M
EBIT 337.80M
Earnings Per Share (EPS) -21.82
Full Income Statement

Balance Sheet

The company has 403.81M in cash and 1.41B in debt, giving a net cash position of -1.00B.

Cash & Cash Equivalents 403.81M
Total Debt 1.41B
Net Cash -1.00B
Retained Earnings 9.26B
Total Assets 10.60B
Working Capital 2.56B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 374.94M and capital expenditures -156.68M, giving a free cash flow of 218.26M.

Operating Cash Flow 374.94M
Capital Expenditures -156.68M
Free Cash Flow 218.26M
FCF Per Share 7.47
Full Cash Flow Statement

Margins

Gross margin is 53.42%, with operating and profit margins of 12.65% and -23.86%.

Gross Margin 53.42%
Operating Margin 12.65%
Pretax Margin -31.82%
Profit Margin -23.86%
EBITDA Margin -22.77%
EBIT Margin 12.65%
FCF Margin 8.17%

Dividends & Yields

BIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -6.07%
FCF Yield 2.17%
Dividend Details

Analyst Forecast

The average price target for BIO is $417.5, which is 16.2% higher than the current price. The consensus rating is "Buy".

Price Target $417.5
Price Target Difference 16.2%
Analyst Consensus Buy
Analyst Count 4
Stock Forecasts

Stock Splits

The last stock split was on Mar 8, 2002. It was a forward split with a ratio of 2:1.

Last Split Date Mar 8, 2002
Split Type forward
Split Ratio 2:1

Scores

Altman Z-Score 3.22
Piotroski F-Score 6